Rajesh Devraj, Ph.D. | Chief Scientific Officer
Rajesh (Raj) brings 20 years of large pharma and biotech industry experience in drug discovery, preclinical and early clinical development, business development and R&D strategy. Raj most recently served as President & CEO of Euclises Pharmaceuticals Inc., a patient-stratified, immune-oncology drug discovery & development company. He previously served as Senior Vice President, Deciphera Pharmaceuticals and prior to that, served as Senior Vice President, Jubilant Drug Discovery & Development. Raj spent 14 years in positions of increasing responsibility with Pfizer Global R&D and legacy Pharmacia and Searle companies. He has led multiple discovery & early clinical development teams that have advanced eight candidates into clinical trials for refractory cancers, rheumatoid arthritis, diabetic nephropathy, COPD and pain. Raj serves as an advisor for Atlas Venture seed stage companies and serves on the board of directors of Euclises Pharmaceuticals, Antegrin Therapeutics and Tansna Therapeutics, Inc. He received his Ph.D. degree in Medicinal Chemistry from Duquesne University and completed his National Cancer Institute Postdoctoral Fellowship at Purdue University. Raj is our staff wine connoisseur.